Skip to main content

Table 1 The relationship between lymphovascular invasion and clinicopathological features of oesophageal squamous cell carcinoma

From: The role of vascular invasion and lymphatic invasion in predicting recurrent thoracic oesophageal squamous cell carcinoma

Variable Total Vascular invasion P value Lymphatic invasion P value
396 Presence(%) Presence(%)
Gender    0.437   0.427
 Male 290 78 (26.9)   72 (24.8)  
 Female 106 24 (22.6)   22 (20.8)  
Age    0.766   0.759
 <65 years 325 85 (26.2)   76 (23.3)  
 ≥65 years 71 17 (23.9)   18 (25.4)  
Smoking status    0.630   0.537
 Non-smoker 138 33 (23.9)   30 (21.7)  
 Smoker 258 69 (26.7)   64 (24.8)  
Tumour location    0.347   0.671
 Upper 35 7 (20.0)   8 (22.9)  
 Middle 253 62 (24.5)   57 (22.5)  
 Lower 108 33 (30.6)   29 (26.9)  
Tumour length    1.000   0.637
 ≤4.0 cm 199 51 (25.6)   45 (22.6)  
 >4.0 cm 197 51 (25.9)   49 (24.9)  
Surgical approach    1.000   0.897
 Right incision 118 30 (25.4)   27 (22.9)  
 Left incision 278 72 (25.9)   67 (24.1)  
Differentiation    0.274   0.997
 G1 119 37 (31.1)   28 (23.5)  
 G2 184 44 (23.9)   44 (23.9)  
 G3 93 21 (22.6)   22 (23.7)  
p T stage    0.013   0.376
 T1+T2 125 22 (17.6)   26 (20.8)  
 T3+T4 271 80 (29.5)   68 (25.1)  
p N stage    <0.001   <0.001
 N0 210 32 (15.2)   33 (15.7)  
 N1+N2+N3 186 70 (37.6)   61 (32.8)  
p TNM stage    <0.001   <0.001
 I stage 49 4 (8.2)   6 (12.2)  
 II stage 164 29 (54.9)   25 (15.2)  
 III stage 170 60 (35.3)   55 (32.4)  
 IV stage 13 9 (69.2)   8 (61.5)  
Relapse type    0.816   0.100
 Lymph node recurrence 78 23 (29.5)   25 (32.1)  
 Metastasis 32 8 (25.0)   5 (15.6)